ArticleFrontiers in genetics2025
Retrospective analysis of non-invasive prenatal testing: a population study involving 19,835 participants in the Shaoyang area.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This cohort study aimed to evaluate the clinical efficacy of Non-invasive prenatal testing (NIPT) in detecting fetal chromosomal abnormalities within a pregnant population in the Shaoyang area, and to further investigate the potential correlation between parental ages and the risk of such abnormalities. Methods: A cohort study was conducted involving 19,835 pregnant women recruited for NIPT between October 2019 and April 2024. The performance of NIPT was assessed based on its positive predictive value (PPV), sensitivity, and specificity. The relationship between parental age and chromosomal abnormalities was analyzed. Results: We identified 88 positive cases, among which Trisomy 13, 18, and 21 accounted for 64 cases. The total PPV was 75.29%. Additionally, we detected 28 cases of sex chromosomal aneuploidies, with an overall PPV of 24.56%. The detection rate of autosomal abnormalities was higher in parents aged 35 years or older (5.49‰) compared to that in the younger parental age group (2.62‰). Unexpectedly, the sex chromosomal abnormalities exhibited an opposite trend, with the younger group demonstrating a higher detection rate of 1.31‰ than the advanced parental age group (0.61‰). All 7 cases of 47,XXY were concentrated among parents under 35 years of age. These results indicate that advanced parental ages are associated with an increased risk of autosome abnormalities; conversely, younger parental ages appear to correlate with a heightened risk of sex chromosome abnormalities. Conclusion: Parental ages may thus influence the occurrence of chromosome abnormalities. Our findings provide novel insights for prenatal genetic counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.